Vitamin B12
Intervention2 papersPubChem 165339223
- Humans1
Trials
57In trials
Vitamin B 12 Deficiency
Phase 4 · Completed · 5 trials
Phase 4 · Completed · 2 trials
Phase 4 · Completed · 1 trial
Phase 4 · Terminated · 1 trial
Phase 4 · Results posted · 1 trial
Phase 4 · Results posted · 1 trial
40 of 53Fewer
Phase 4 · Results posted · 1 trial
Lymphoma, T-Cell, Peripheral
Phase 3 · Results posted · 4 trials
T-Cell Lymphoma
Phase 3 · Results posted · 3 trials
Phase 3 · Results posted · 2 trials
Transitional Cell Carcinoma
Phase 3 · Status unknown · 2 trials
Urinary Bladder Neoplasms
Phase 3 · Status unknown · 2 trials
Phase 3 · Completed · 1 trial
Phase 3 · Results posted · 1 trial
Phase 3 · Completed · 1 trial
Phase 2/3 · Completed · 2 trials
Phase 2/3 · Completed · 1 trial
Phase 2/3 · Status unknown · 1 trial
Phase 2/3 · Terminated · 1 trial
Phase 2/3 · Status unknown · 1 trial
Phase 2/3 · Completed · 1 trial
Recurrence
Phase 2 · Results posted · 7 trials
Non-Small-Cell Lung Carcinoma
Phase 2 · Results posted · 5 trials
Lung Neoplasms
Phase 2 · Results posted · 4 trials
Neoplasm Metastasis
Phase 2 · Results posted · 3 trials
B-Cell Lymphoma
Phase 2 · Results posted · 2 trials
Breast Neoplasms
Phase 2 · Results posted · 2 trials
Head and Neck Neoplasms
Phase 2 · Results posted · 2 trials
Brain edema
Phase 2 · Terminated · 1 trial
Phase 2 · Completed · 1 trial
Phase 2 · Status unknown · 1 trial
Phase 2 · Completed · 1 trial
Phase 2 · Completed · 1 trial
Diarrhea
Phase 2 · Completed · 1 trial
Phase 2 · Completed · 1 trial
Phase 2 · Status unknown · 1 trial
Phase 2 · Completed · 1 trial
Phase 2 · Completed · 1 trial
Phase 2 · Completed · 1 trial
Phase 2 · Results posted · 1 trial
Stopped
NCT02120274 · Terminated · Hepatitis C
New Brazilian Guidelines for Viral Hepatitis C and Coinfetions. It does not include the treatment of chronic HCV Metavir \< F3 and abandon the use of interferon.
NCT00208611 · Terminated · Parkinson's disease
Funding ended and enrollment not completed within a certain time period
NCT00402883 · Terminated · Lung Neoplasms
Terminated due to bevacizumab and chemoradiotherapy toxicity
NCT02795572 · Terminated · Breast Neoplasms
Retirement of the Principal Investigator
NCT00243022 · Terminated · Brain edema
Slow accrual
NCT01704599 · Terminated · Psoriasis
side effect and poor clinical outcome
Trial sponsors
Medice Arzneimittel Pütter GmbH & Co KG
Company1 trialPhase 446 people
Company1 trialPhase 412 people
Company1 trialPhase 3156 people
Mundipharma (China) Pharmaceutical Co. Ltd
Company1 trialPhase 385 people
Company6 trialsPhase 2296 people
Company3 trialsPhase 2196 people
Company2 trialsPhase 2230 people
Company1 trialPhase 1/225 people
Latest
23High serum vitamin B12 is linked to modest cancer risk
Cancer incidence rose modestly above baseline with adjusted hazard ratios of 1.05 to 1.08, while mortality followed a J-shaped pattern across serum…Cancer incidence rose modestly above baseline with adjusted hazard ratios of 1.05 to 1.08, while mortality followed a J-shaped pattern across serum vitamin B12 strata.
Nutrient deficits linked to higher metabolic risks in obesity
Compared to patients without nutritional deficiencies, vitamin D and B12 deficits carried median hazard ratios of 3.09 and 2.49 for metabolic diseases…Compared to patients without nutritional deficiencies, vitamin D and B12 deficits carried median hazard ratios of 3.09 and 2.49 for metabolic diseases in obesity.